The Orally Active Nonpeptide Endothelin A-Receptor Antagonist A-127722 Prevents and Reverses Hypoxia-Induced Pulmonary Hypertension and Pulmonary Vascular Remodeling in Sprague-Dawley Rats-Reference-Cited by-同舟云学术

The Orally Active Nonpeptide Endothelin A-Receptor Antagonist A-127722 Prevents and Reverses Hypoxia-Induced Pulmonary Hypertension and Pulmonary Vascular Remodeling in Sprague-Dawley Rats

Published:1997-06 Issue:6 Volume:29 Page:713-725
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:Journal of Cardiovascular Pharmacology

Author:

Chen Shi-Juan,Chen Yiu-Fai,Opgenorth Terry J.,Wessale Jerry L.,Meng Qing Cheng,Durand Joan,DiCarlo Vick S.,Oparil Suzanne

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference47 articles.

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells

2. Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle,

3. Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension

4. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium.

5. Effect of hypoxia on plasma immunoreactive endothelin-1 concentration in anesthetized rats

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular pathobiology of pulmonary hypertension;The Journal of Heart and Lung Transplantation;2023-05

2. Macitentan in the treatment of pulmonary arterial hypertension;Future Cardiology;2021-01

3. The endothelin system as target for therapeutic interventions in cardiovascular and renal disease;Clinica Chimica Acta;2020-07

4. Cardiovascular Research;The Laboratory Rat;2020

5. Rho kinase and Na+ /H+ exchanger mediate endothelin-1-induced pulmonary arterial smooth muscle cell proliferation and migration;Physiological Reports;2018-05